Literature DB >> 25654572

Adolescents at risk: pain pills to heroin: part II.

Susanne Fogger, Teena M McGuinness.   

Abstract

Casually exposing adolescents to prescription opioid agents may escalate to daily use. A trend exists for adolescents using prescription opioid agents to substitute heroin because it is significantly cheaper than pills (approximately half of the cost) and is often more readily available. Additionally, it is more potent than most prescription opioid agents and carries increased risks of overdose and death. Although treatment for substance use disorders has traditionally centered on total abstinence, opioid replacement therapy (ORT) is an option that saves lives and prevents overdose deaths. In the United States, ORT is based on two medicines: methadone and buprenorphine. These drugs can be substituted for other opiate agents and have much lower overdose risks. Nursing implications and web-based resources for teaching are presented. Copyright 2015, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25654572     DOI: 10.3928/02793695-20150106-01

Source DB:  PubMed          Journal:  J Psychosoc Nurs Ment Health Serv        ISSN: 0279-3695            Impact factor:   1.098


  3 in total

1.  Medication-Assisted Treatment for Adolescents in Specialty Treatment for Opioid Use Disorder.

Authors:  Kenneth A Feder; Noa Krawczyk; Brendan Saloner
Journal:  J Adolesc Health       Date:  2017-03-01       Impact factor: 5.012

2.  Prescription opioid use disorder and heroin use among 12-34 year-olds in the United States from 2002 to 2014.

Authors:  Silvia S Martins; Luis E Segura; Julian Santaella-Tenorio; Alexander Perlmutter; Miriam C Fenton; Magdalena Cerdá; Katherine M Keyes; Lilian A Ghandour; Carla L Storr; Deborah S Hasin
Journal:  Addict Behav       Date:  2016-08-30       Impact factor: 3.913

Review 3.  A Scoping Review of Nursing's Contribution to the Management of Patients with Pain and Opioid Misuse.

Authors:  Janet H Van Cleave; Staja Q Booker; Keesha Powell-Roach; Eva Liang; Jennifer Kawi
Journal:  Pain Manag Nurs       Date:  2021-01-05       Impact factor: 1.929

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.